Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Large Cell Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01741792
What this trial is testing

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
Amgen Research (Munich) GmbH 25
Large-scale testing (Phase 3)Study completedNCT00790036
What this trial is testing

Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy

Who this might be right for
Diffuse Large B-cell Lymphoma
Novartis Pharmaceuticals 742
Early research (Phase 1)Active Not RecruitingNCT05688475
What this trial is testing

A Rollover Study of CC-122

Who this might be right for
Non-Hodgkin Lymphoma
Bristol-Myers Squibb 12
Post-approval studies (Phase 4)UnknownNCT01746992
What this trial is testing

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

Who this might be right for
ALK-negative Anaplastic Large Cell LymphomaPeripherial T Cell Lymphoma,Not Otherwise SpecifiedAngioimmunoblastic T Cell Lymphoma+3 more
Ruijin Hospital 200
Not applicableEnded earlyNCT03436771
What this trial is testing

Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product

Who this might be right for
Non Hodgkin LymphomaMultiple MyelomaChronic Lymphocytic Leukemia+3 more
Juno Therapeutics, a Subsidiary of Celgene 4
Not applicableStudy completedNCT00005799
What this trial is testing

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more
Fred Hutchinson Cancer Center 55
Large-scale testing (Phase 3)Study completedNCT00003414
What this trial is testing

Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease

Who this might be right for
Graft Versus Host DiseaseLymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Large-scale testing (Phase 3)UnknownNCT00003337
What this trial is testing

Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Gilead Sciences 100
Early research (Phase 1)Active Not RecruitingNCT02051257
What this trial is testing

Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Mantle Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma+2 more
City of Hope Medical Center 51
Testing effectiveness (Phase 2)WithdrawnNCT00621036
What this trial is testing

Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaLymphoproliferative Disorder+1 more
University of Texas Southwestern Medical Center
Early research (Phase 1)WithdrawnNCT00458744
What this trial is testing

Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+1 more
Children's Oncology Group
Not applicableWithdrawnNCT05160064
What this trial is testing

Long-term Registry of Patients Treated With Loncastuximab Tesirine

Who this might be right for
B-Cell Lymphomas
ADC Therapeutics S.A.
Testing effectiveness (Phase 2)Study completedNCT00546793
What this trial is testing

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

Who this might be right for
NHLLymphoma, Non-HodgkinLymphoma, B-Cell+15 more
Gilead Sciences 32
Early research (Phase 1)Study completedNCT00049699
What this trial is testing

VNP40101M in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Vion Pharmaceuticals
Early research (Phase 1)Study completedNCT00031941
What this trial is testing

CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Not Yet RecruitingNCT07638982
What this trial is testing

Axatilimab + CAR-T for High-Risk Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell LymphomaHigh-grade B-cell Lymphoma (HGBCL)+3 more
Northside Hospital, Inc. 29
Early research (Phase 1)Study completedNCT00416923
What this trial is testing

Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphoma
University of California, San Francisco 10
Early research (Phase 1)Study completedNCT00430846
What this trial is testing

Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies

Who this might be right for
Lymphoma, Non-HodgkinDisease, HodgkinLymphoma, Large-Cell, Anaplastic
Seagen Inc. 45
Testing effectiveness (Phase 2)Study completedNCT00601718
What this trial is testing

Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+34 more
University of Washington 29
Testing effectiveness (Phase 2)UnknownNCT00363090
What this trial is testing

Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Toronto Sunnybrook Regional Cancer Centre 84
Next Page